Statins for Venous Event Reduction in Patients With Venous Thromboembolism

Recruiting

Phase 3

Statins for Venous Event Reduction in Patients With Venous ThromboembolismStatins for Venous Event Reduction in Patients With Venous Thromboembolism

Sponsor:

Ottawa Hospital Research Institute

Code:

NCT04319627

Conditions

Venous Thromboembolism

Blood Clot

Post Thrombotic Syndrome

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Rosuvastatin Calcium

Placebo Oral Tablet

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by Ottawa Hospital Research Institute on 2023-05-31.